intarcia-article-landing-page-image.2

[device]

Refer your high-risk cardiovascular patients for study participation today!

 

An innovative approach to delivering treatment that does not require needles or pills.

ITCA 650 (exenatide in DUROS® device) is an investigational drug product that is being developed for the treatment of Type 2 Diabetes. ITCA 650 is a match stick sized titanium cylinder placed just under the skin in the abdomen where it slowly delivers a continuous and consistent subcutaneous infusion of exenatide for up to six months.

Participants must: 

be at least 40 years of age
be diagnosed with Type 2 Diabetes for at least 3 months
have a history of coronary, cerebrovascular, or peripheral artery disease

Participants will receive:

 the investigational product   (active treatment or placebo)
 all study-related care at no cost

For additional details, contact Intarcia today! Via phone at: 1-855-936-2555 Or e-mail: FREEDOMCVOStudy@intarcia.com

[/device]

[notdevice]

 

Refer your high-risk cardiovascular patients for study participation today!

 

An innovative approach to delivering treatment that does not require needles or pills.

ITCA 650 (exenatide in DUROS® device) is an investigational drug product that is being developed for the treatment of Type 2 Diabetes. ITCA 650 is a match stick sized titanium cylinder placed just under the skin in the abdomen where it slowly delivers a continuous and consistent subcutaneous infusion of exenatide for up to six months.


Participants must:
 

be at least 40 years of age

be diagnosed with Type 2 Diabetes for at least 3 months

have a history of coronary, cerebrovascular, or peripheral artery disease

Participants will receive:

 the investigational product
  (active treatment or placebo)

 all study-related care at no cost

For additional details, contact Intarcia today!
Via phone at: 1-855-936-2555
Or e-mail: FREEDOMCVOStudy@intarcia.com

[/notdevice]
 

Author